Chang; Guodong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chang; Guodong.The latest application filed is for "pegylated endostatin analogue and application thereof".

Company Profile

4.10.26

Chang; Guodong - Beijing CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pegylated endostatin analogue and application thereof Grant 11,098,104 - Zhou , et al. August 24, 2	2021-08-24
Pegylated Endostatin Analogue And Application Thereof App 20200270333 - Zhou; Daifu ; et al.	2020-08-27
Medication For Inhibiting Dna-pkcs App 20200237796 - LUO; Yongzhang ; et al.	2020-07-30
Endostatin mutants with mutations at ATP binding sites Grant 10,647,968 - Luo , et al.	2020-05-12
Construction Of Engineering Bacteria For High Expression Of Recombinant Human Serum Albumin App 20190330707 - Chang; Guodong ; et al.	2019-10-31
Medicament For Treatment Of Tumors And The Use Thereof App 20180360922 - LUO; Yongzhang ; et al.	2018-12-20
Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapy Grant 10,054,590 - Luo , et al. August 21, 2	2018-08-21
Method For Inhibiting Lymphangiogenesis By Administration Of An Inhibitor Of The Cxcl12 Pathway App 20180094051 - LUO; Yongzhang ; et al.	2018-04-05
Method of inhibiting or treating cancer metastasis Grant 9,815,906 - Luo , et al. November 14, 2	2017-11-14
Tumor Biomarker App 20160178633 - Luo; Yongzhang ; et al.	2016-06-23
Methods and compositions for enhancing the uptake of therapeutic agents by target cells Grant 9,364,493 - Luo , et al. June 14, 2	2016-06-14
Method For Cancer Detection App 20150259432 - LUO; Yongzhang ; et al.	2015-09-17
Endostatin Mutants With Mutations At Atp Binding Sites App 20150197733 - Luo; Yongzhang ; et al.	2015-07-16
Method for cancer detection Grant 8,975,030 - Luo , et al. March 10, 2	2015-03-10
Methods And Compositions For Enhancing The Uptake Of Therapeutic Agents By Target Cells App 20140335152 - LUO; Yongzhang ; et al.	2014-11-13
Endostatin Mutants With Mutations At Atp Binding Sites App 20140308263 - Luo; Yongzhang ; et al.	2014-10-16
Method And Medicament For Inhibiting Lymphangiogenesis App 20140193424 - LUO; Yongzhang ; et al.	2014-07-10
Methods And Compositions For Enhancing The Uptake Of Therapeutic Agents By Target Cells App 20140147492 - Luo; Yongzhang ; et al.	2014-05-29
Conjugate Angiostation Or Its Fragment, The Method Of Producing The Conjugate And Use Thereof App 20140056966 - LUO; Yongzhang ; et al.	2014-02-27
Use Of Nucleolin As A Biomarker For Lymphangiogenesis In A Cancer Prognosis And Therapy App 20140037655 - LUO; YONGZHANG ; et al.	2014-02-06
Method For Cancer Detection App 20130243757 - Luo; Yongzhang ; et al.	2013-09-19
Tumor biomarker Grant 8,389,684 - Luo , et al. March 5, 2	2013-03-05
Use Of Nucleolin As A Biomarker For Lymphangiogenesis In Cancer Prognosis And Therapy App 20130023479 - Luo; Yongzhang ; et al.	2013-01-24
Novel Tumor Biomarket App 20120064078 - LUO; Yongzhang ; et al.	2012-03-15
Novel Compound For Treatment Of Tumor App 20100303893 - Luo; Yongzhang ; et al.	2010-12-02
Medicament For Treatment Of Tumors And The Use Thereof App 20100285103 - Luo; Yongzhang ; et al.	2010-11-11
Conjugate Comprising Angiostation Or Its Fragment, The Method For Producing The Conjugate And Use Thereof App 20100184661 - Luo; Yongzhang ; et al.	2010-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.